First Trust NYSE Arca Biotechnology Index Fund
112 hedge funds and large institutions have $398M invested in First Trust NYSE Arca Biotechnology Index Fund in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4.12% more ownership
Funds ownership: 34.89% → 39.02% (+4.1%)
0% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 22
1% less funds holding
Funds holding: 113 → 112 (-1)
Holders
112
Holding in Top 10
4
Calls
$1.66M
Puts
$1.35M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$11M | |
| 3 | +$6.64M | |
| 4 |
CM
Churchill Management
Los Angeles,
California
|
+$4.47M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.45M |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$2.18M | |
| 3 | -$1.31M | |
| 4 |
CWM
Concert Wealth Management
San Jose,
California
|
-$1.2M |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$949K |